Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caligan Partners is a healthcare-focused activist investment firm based in New York. Founded in 2017 by David Johnson, the firm specializes in identifying undervalued companies in the life sciences, biotechnology, and medical technology sectors. Caligan typically takes significant equity positions in public companies and engages with management and boards to drive operational improvements, strategic shifts, or corporate governance changes. The firm has been notably involved in proxy contests and board representation at companies such as Exelixis, Liquidia Corporation, Alimera Sciences, and Anika Therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Funds affiliated with David Johnson.